Top Upgrades
- Raymond James upgraded Amazon.com, Inc. (NASDAQ:AMZN) from Market Perform to Outperform. Amazon shares rose 7.46 percent to $1,045.00 in pre-market trading.
- Stifel Nicolaus upgraded Quintiles IMS Holdings Inc (NYSE:Q) from Hold to Buy. Quintiles IMS shares gained 3.94 percent to close at $105.50 on Thursday.
- Needham upgraded First Solar, Inc. (NASDAQ:FSLR) from Hold to Buy. First Solar shares rose 9.18 percent to $52.32 in pre-market trading.
- Compass Point upgraded Radian Group Inc (NYSE:RDN) from Neutral to Buy. Radian shares rose 3.01 percent to close at $20.90 on Thursday.
- JP Morgan upgraded Imax Corp (USA) (NYSE:IMAX) from Neutral to Overweight. Imax shares rose 2.35 percent to $23.95 in pre-market trading.
- Monness Crespi Hardt upgraded Facebook Inc (NASDAQ:FB) from Neutral to Buy. Facebook shares gained 2.05 percent to $174.13 in pre-market trading.
- Evercore ISI Group upgraded Corporate Office Properties Trust (NYSE:OFC) from Underperform to In-Line. Corporate Office Properties shares slipped 0.03 percent to close at $31.15 on Thursday.
- Analysts at Morgan Stanley upgraded Celgene Corporation (NASDAQ:CELG) from Underweight to Equal-Weight. Celgene shares gained 0.23 percent to $100.22 in pre-market trading.
- Analysts at Raymond James upgraded Cullen/Frost Bankers, Inc. (NYSE:CFR) from Underperform to Market Perform. Cullen/Frost Bankers shares gained 0.95 percent to close at $100.47 on Thursday.
Top Downgrades
- Analysts at William Blair downgraded Electronics For Imaging, Inc. (NASDAQ:EFII) from Outperform to Market Perform. Electronics for Imaging shares fell 22.86 percent to $32.50 in pre-market trading.
- SunTrust Robinson Humphrey downgraded Dynegy Inc. (NYSE:DYN) from Buy to Hold. Dynegy shares rose 0.72 percent to $11.26 in pre-market trading.
- JP Morgan downgraded Cerner Corporation (NASDAQ:CERN) from Overweight to Neutral. Cerner shares fell 8.30 percent to $65.40 in pre-market trading.
- Evercore ISI Group downgraded Tesla Inc (NASDAQ:TSLA) from Outperform to In-Line. Tesla shares declined 1.31 percent to $321.90 in pre-market trading.
- Analysts at Piper Jaffray downgraded Michaels Companies Inc (NASDAQ:MIK) from Neutral to Underweight. Michaels Companies shares rose 0.48 percent to close at $21.13 on Thursday.
- Stifel Nicolaus downgraded Gigamon Inc (NYSE:GIMO) from Buy to Hold. Gigamon shares gained 6.09 percent to $38.35 in pre-market trading.
- Evercore ISI Group downgraded Teradyne, Inc. (NYSE:TER) from Outperform to In-Line. Teradyne shares gained 7.44 percent to close at $42.03 on Thursday.
- Credit Suisse downgraded Mercer International Inc. (NASDAQ:MERC) from Outperform to Neutral. Mercer shares fell 0.35 percent to $14.05 in pre-market trading.
- Mizuho downgraded Dunkin Brands Group Inc (NASDAQ:DNKN) from Neutral to Underperform. Dunkin Brands shares rose 0.43 percent to close at $55.63 on Thursday.
- Morgan Stanley downgraded Ingersoll-Rand PLC (NYSE:IR) from Overweight to Equal-Weight. Ingersoll-Rand shares fell 0.72 percent to close at $90.66 on Thursday.
Top Initiations
- Canaccord Genuity initiated coverage on Biogen Inc (NASDAQ:BIIB) with a Hold rating. The price target for Biogen is set to $340. Biogen shares closed at $307.64 on Thursday.
- Wells Fargo initiated coverage on Black Hills Corp (NYSE:BKH) with a Market Perform rating. The price target for Black Hills is set to $58. Black Hills shares closed at $65.09 on Thursday.
- Canaccord Genuity initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR) with a Buy rating. The price target for Voyager Therapeutics is set to $35. Voyager Therapeutics shares closed at $21.54 on Thursday.
- Analysts at SunTrust Robinson Humphrey initiated coverage on Okta Inc (NASDAQ:OKTA) with a Buy rating. The price target for Okta is set to $36. Okta shares closed at $27.59 on Thursday.
- Analysts at Compass Point initiated coverage of Granite Point Mortgage Trust Inc (NYSE:GPMT) with a Buy rating. The price target for Granite Point Mortgage is set to $19.50. Granite Point Mortgage shares closed at $18.13 on Thursday.
- Analysts at Canaccord Genuity initiated coverage on Alder Biopharmaceuticals Inc (NASDAQ:ALDR) with a Buy rating. The price target for Alder Biopharmaceuticals is set to $20. Alder Biopharmaceuticals shares closed at $10.35 on Thursday.
- Analysts at Mizuho initiated coverage on CalAtlantic Group Inc (NYSE:CAA) with a Buy rating. The price target for CalAtlantic is set to $45. CalAtlantic shares closed at $39.98 on Thursday.
BIIBBiogen Inc
$173.76-0.19%
BKHBlack Hills Corp
$73.25-1.54%
CFRCullen/Frost Bankers Inc
$128.56-0.51%
DYNDyne Therapeutics Inc
$19.360.44%
FBProShares S&P 500 Dynamic Buffer ETF
$42.170.20%
FSLRFirst Solar Inc
$253.26-0.60%
GPMTGranite Point Mortgage Trust Inc
$2.63-0.75%
IMAXImax Corp
$39.132.52%
IRIngersoll Rand Inc
$81.17-0.72%
MERCMercer International Inc
$1.94-1.79%
OKTAOkta Inc
$89.82-1.63%
QQnity Electronics Inc
$79.290.44%
RDNRadian Group Inc
$35.920.11%
TERTeradyne Inc
$195.661.18%
TSLATesla Inc
$476.563.83%
VYGRVoyager Therapeutics Inc
$4.26-2.96%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
